Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Long-Term Efficacy of Vatiquinone for the Treatment of Friedreich's Ataxia

NCT07681713 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT07681713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07681713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Long-Term Efficacy of Vatiquinone for the Treatment of Friedreich's Ataxia
Lead sponsor
PTC Therapeutics
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
March 15, 2029
Enrollment
120 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich's ataxia